Elixxer (Elixxer) Asset Impairment Charge : $0.00 Mil (TTM As of Sep. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Elixxer Asset Impairment Charge?

Elixxer's Asset Impairment Charge for the three months ended in Sep. 2023 was $0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 was $0.00 Mil.

Elixxer Asset Impairment Charge Historical Data

The historical data trend for Elixxer's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer Asset Impairment Charge Chart

Elixxer Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Sep17

Sep18

Dec20

Dec21

Dec22

Asset Impairment Charge

Get a 7-Day Free Trial

1.93

1.47

Elixxer Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Elixxer Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Elixxer Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Elixxer's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixxer (Elixxer) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4

Website

https://www.elixxer.com

Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.